0B68 Nevalainen, Marja - Thomas Jefferson University - Thomas Jefferson University
mtn006

Marja Nevalainen, MD, PhD

Contact Dr. Nevalainen

Kimmel Cancer Center
233 S. Tenth Street, Suite 309B
Philadelphia, PA 19107

(215) 503-9250
(215) 503-9245 fax

Most Recent Peer-reviewed Publications

  1. Pharmacologic inhibition of Jak2-Stat5 signaling by Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer
  2. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  3. Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy
  4. Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity
  5. Reply to A. Italiano
  6. Prolactin regulation of the prostate gland: A female player in a male game
  7. Signal transducer and activator of transcription 5a/b: Biomarker and therapeutic target in prostate and breast cancer
  8. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure
  9. Targeting transcription factor stat5a/b as a therapeutic strategy for prostate cancer
  10. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells
  11. Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer
  12. Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
  13. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth
  14. Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer
  15. Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor
  16. Signal transducer and activator of transcripti 0769 on 5A/B in prostate and breast cancers
  17. Stat3 promotes metastatic progression of prostate cancer
  18. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo
  19. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells
  20. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway
0